Elizabeth G. Posillico

President & Chief Executive Officer at Elusys Therapeutics, Inc.

Elizabeth G. Posillico

Elizabeth G. Posillico

President & Chief Executive Officer at Elusys Therapeutics, Inc.

Overview
Career Highlights

Elusys Therapeutics, Inc.

RelSci Relationships

1996

Number of Boards

6

Relationships
RelSci Relationships are individuals Elizabeth G. Posillico likely has professional access to. A relationship does not necessarily indicate a personal connection.

Adjunct Partner at Essex Woodlands Management, Inc.

Relationship likelihood: Strong

Chairman of the Board, Chief Executive Officer & President at Soligenix, Inc.

Relationship likelihood: Strong

Managing Director at Essex Woodlands Management, Inc.

Relationship likelihood: Strong

Former Development Director at Prolong Pharmaceuticals LLC

Relationship likelihood: Strong

Chief Business Officer at Symbiomix Therapeutics LLC

Relationship likelihood: Strong

Senior Advisor at The Blackstone Group, Inc.

Relationship likelihood: Strong

Managing Director, Investment Banking at SVB Leerink LLC

Relationship likelihood: Strong

Managing Director at Seed-One Ventures LLC

Relationship likelihood: Strong

Founder at Centrexion Therapeutics Corp.

Relationship likelihood: Strong

Former President & Chief Executive Officer at Chimerix, Inc.

Relationship likelihood: Strong

Paths to Elizabeth G. Posillico
Potential Connections via
Relationship Science
You
Elizabeth G. Posillico
President & Chief Executive Officer at Elusys Therapeutics, Inc.
Education
PhD

Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC.

BA

SUNY at Potsdam is a school in Potsdam.

Memberships
Career History
Vice President-Business Development & Marketing
Tenure Unconfirmed

Physiome Sciences, Inc. provides computer-based modeling and simulation of cells, and biological systems for drug development. The company was founded by Donna Rounds and is headquartered in Princeton, NJ.

General Manager
Prior

Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA.

President & Chief Executive Officer
2002 - Current

Elusys Therapeutics, Inc. develops antibody therapies. It is engaged in development Anthim (oblitoxaximab) a mAb anthrax antitoxin for the treatment and prevention of inhalational anthrax used in a bioterror attack. The company was founded in May 1998 and is headquartered in Pine Brook, NJ.

Boards & Committees
Director
2002 - Current

Elusys Therapeutics, Inc. develops antibody therapies. It is engaged in development Anthim (oblitoxaximab) a mAb anthrax antitoxin for the treatment and prevention of inhalational anthrax used in a bioterror attack. The company was founded in May 1998 and is headquartered in Pine Brook, NJ.

Member, Management Committee
Prior
Co-Chairman
2013 - Prior
Director
Prior

GIRL SCOUTS OF NORTHERN NEW JERSEY BUILDS GIRLS OF COURAGE, CONFIDENCE, AND CHARACTER WHO MAKE THE WORLD A BETTER PLACE.

Political Donations
$500
2007

House Committee on Education and the Workforce: Subcommittee on Workforce Protections

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Elizabeth G. Posillico. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Elizabeth G. Posillico's profile does not indicate a business or promotional relationship of any kind between RelSci and Elizabeth G. Posillico.